JNJ vs PFE
Johnson & Johnson (JNJ) and Pfizer (PFE) compared side by side. Johnson & Johnson (JNJ) is larger, with a market cap of $635.1B versus $171.2B for Pfizer, about 3.7 times the size. On trailing earnings, PFE is cheaper at 39.5x versus 40.0x for JNJ.
Head to head
| Metric | JNJ | PFE |
|---|---|---|
| Market cap | $635.1B | $171.2B |
| P/E (TTM) | 40.0x | 39.5x |
| Forward P/E | 22.7x | 10.4x |
| Revenue (TTM) | $99.3B | $63.7B |
| Revenue growth | 5.9% | 2.6% |
| Gross margin | 67.8% | 74.7% |
| Operating margin | 25.7% | 27.9% |
| Free cash flow | $22.2B | $11.0B |
| Dividend yield | 2.03% | 5.73% |
| 1-year return | +40.2% | +30.3% |
| 5-year return (annual) | +13.1% | -1.9% |
| Max drawdown | -51% | -69% |
| FI Handbook grade | B- | C+ |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
JNJ vs PFE FAQ
Which is bigger, JNJ or PFE?
Johnson & Johnson (JNJ) is larger, with a market cap of $635.1B versus $171.2B for Pfizer, about 3.7 times the size.
Is JNJ or PFE cheaper?
On trailing earnings, PFE is cheaper at 39.5x versus 40.0x for JNJ. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, JNJ or PFE?
JNJ returned +40.2% over the past year including dividends, versus +30.3% for PFE, through October 23, 2026.
Which pays a higher dividend, JNJ or PFE?
PFE yields 5.73% versus 2.03% for JNJ.
Full pages: Johnson & Johnson · Pfizer